Stocks and Investing Stocks and Investing
Wed, November 20, 2013
Tue, November 19, 2013
Mon, November 18, 2013
Fri, November 15, 2013
Thu, November 14, 2013
Wed, November 13, 2013
Tue, November 12, 2013

Joseph Schwartz Maintained (SRPT) at Hold with Decreased Target to $17 on, Nov 12th, 2013


Published on 2024-10-25 03:40:52 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Swann, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Hold with Decreased Target from $44 to $17 on, Nov 12th, 2013.

Joseph has made no other calls on SRPT in the last 4 months.



There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Citigroup" Initiated at Hold on, Tuesday, August 27th, 2013
Contributing Sources